FDA Drug Application (020401) for TIAZAC by VALEANT PHARMS NORTH

Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Application Number020401
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage120MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB4 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTIAZAC
Active IngredientDILTIAZEM HYDROCHLORIDE



Back to FDA Applications sponsored by VALEANT PHARMS NORTH

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.